GlassScriptPhysician profile
Darryl D Prime
NPI 1982668828
$14,745.81
in general payments reported to CMS, 2019-2025
27 companies · $647 in 2025
The $647 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,347 · 2020: $777 · 2021: $6,083 · 2022: $2,690 · 2023: $1,327 · 2024: $876 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,680 · Travel and Lodging: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,680.11 |
| Travel and Lodging | $169.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11,308.06 | 2019-2025 | Lifevest |
| Zoll Circulation INC | $406.18 | 2023 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Abiomed | $405.57 | 2022-2025 | Impella |
| Abbott Laboratories | $328.67 | 2019-2025 | Mitraclip, Triclip |
| Philips North America LLC | $287.19 | 2019-2024 | (Bq9) Coronary Ivus, (Br0) Coronary Atherectomy, (P84) Igt Devices Systems |
| Novartis Pharmaceuticals Corporation | $270.62 | 2019-2025 | |
| Medtronic, INC. | $217.96 | 2023-2024 | Corevalve Evolut R, Ffrangio, Euphora |
| Penumbra, INC. | $214.73 | 2025 | Indigo System, Penumbra System |
| Cardiovascular Systems INC. | $198.88 | 2023 | Diamondback Peripheral |
| Janssen Pharmaceuticals, INC | $188.19 | 2021-2024 | Xarelto |
| Inari Medical, INC. | $178.83 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $159.94 | 2023-2024 | Avvigo Guidance System |
| Angiodynamics, INC. | $143.64 | 2025 | Alphavac, Angiovac |
| Pfizer INC. | $97.99 | 2022-2025 | |
| Amgen INC. | $58.58 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $42.06 | 2024 | Xarelto |
| Chiesi USA, INC. | $40.61 | 2025 | Kengreal |
| Teleflex LLC | $32.68 | 2024 | Manta |
| Terumo Medical Corporation | $22.60 | 2019 | |
| Irhythm Technologies, INC. | $21.32 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.58 | 2022 | |
| Shockwave Medical, INC | $19.74 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Alnylam Pharmaceuticals INC. | $19.42 | 2025 | Amvuttra |
| Lantheus Medical Imaging, INC. | $19.21 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.63 | 2021 | |
| Merck Sharp & Dohme LLC | $13.62 | 2022 | |
| Astellas Pharma US INC | $13.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darryl Prime listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.